Abstract
Two of glucagon’s many pharmacological properties are utilised clinically for the diagnosis and treatment of hypoglycaemia. They are its ability: (1) to raise the blood glucose concentration by increasing hepatic glycogenolysis; and (2) to stimulate insulin secretion by direct action on pancreatic B-cells. Though still widely used for the treatment of acute episodes of iatrogenic hypoglycaemia in insulin-dependent subjects, the advent of more specific and more effective treatments has reduced almost to zero the usefulness of glucagon as a therapy for chronic hypoglycaemia. Similarly, the availability of improved diagnostic procedures for hyperinsulinism, glycogen storage disease and the various endocrinopathies associated with, and causative of, spontaneous hypoglycaemia has reduced the usefulness of glucagon in the differential diagnosis of these disorders to that of an adjunct rather than a key.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alaric R (1973) Hypoglycémie prolongée au chlorpropamide. Union Med Can 102: 1290–1291
Alivisatos JG, McCullagh EP (1955) Studies with glucagon in patients with insulin sensitivity. JAMA 159: 1098–1105
Arieff A, Crawford J, Adams J, Smith D (1960) Glucagon in insulin coma therapy: its use in a small psychiatric unit of a general hospital. Q Bull Northwest Univ Med Sch 34: 7–10
Arky RA, Finger M, Veverbrants E, Braun AP (1970) Glucose and insulin response to intravenous glucagon during starvation. Am J Clin Nutr 23: 69–95
Aynsley-Green A, Williamson DH, Gitzelmann R (1977) Hepatic glycogen synthetase deficiency: definition of syndrome and enyzme studies on a 9-year-old girl. Arch Dis Child 52: 573–579
Baerlocher K, Gitzelmann R, Steinman B, Gitzelmann-Cumarasamy N (1978) Hereditary fructose intolerance in early childhood: a major challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta 33: 465–487
Baker L, Winegrad AI (1970) Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet 2: 13–16
Beck-Christiansen O (1964) Metastasizing insulinoma treated with glucagon. Dan Med Bull 11: 70–72
Benedetti A (1971) The glucagon plus galactose tolerance. In: Austoni M, Scandellari C, Federspil G, Trisotto A (eds) Current topics on glucagon. Cedam, Padova, pp 177–191
Benedetti A, Kolb FO (1966) Metabolic effects and epinephrine in four adults with type I glycogen storage disease. Diabetes 15: 529
Benedetti A, Simpson RG, Grodsky GM, Forsham PH (1967) Exaggerated insulin response to glucagon in simple obesity. Diabetes 16: 666–669
Bergman H (1965) Hypoglycaemic coma during sulphonylurea therapy. Acta Med Scand 177: 287–298
Braun M, Parker M (1959) The use of glucagon in the termination of therapeutic insulin coma. Am J Psychiatry 115: 814–815
Brennan MO, Service F J, Carpenter AM, Rubenstein AH, Edis AJ (1980) A complex case of hypoglycemia diagnosed by C-peptide suppression test. In: Andreani D, Lefèbvre PJ, Marks V (eds) Current views on hypoglycaemia and glucagon. Academic, London, pp 321–330
Broberger O, Jungner I, Zetterstrôm R (1959) Studies in spontaneous hypoglycemia in childhood: failure to increase the epinephrine secretion in insulin-induced hypoglycemia. J Pediatr 55: 713–719
Carson MJ, Koch R (1955) Clinical studies with glucagon in children. J Pediatr 47:161–170
Chalmers RA, Ryman BE, Watts RWE (1978) Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro. Acta Paediatr Scand 67: 201–207
Charles MA, Hofeldt F, Shackleford A, Waldeck N, Dobson LE, Bunker D, Coggins JT, Eichner H (1981) Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic postabsorptive hypoglycemia: absence of hypoglycemia after meals. Diabetes 30: 465–470
Chowdhury F, Bleicher S J (1973) Studies of tumor hypoglycemia. Metabolism 22: 663–674
Codaccioni JL, Rubin P, Mattei A, Vague P (1971) Quatre hypoglycémies graves donc une mortelle au cours du traitement par glibenclamide. Diab Metab 19: 37–41
Colle E, Ulström RA (1964) Ketotic hypoglycemia. J Pediatr 64: 632–651
Colwell JA, Wilber JF (1971) Studies of insulin and growth hormone secretion in a subject with hepatoma and hypoglycemia. Diabetes 20: 607–614
Cornblath M, Schwartz R (1976) Disorders of carbohydrate metabolism in infancy, 2nd edn. Saunders, Philadelphia
Creutzfeldt W, Frerichs H, Perings F (1969) Serum insulin levels in hypoglycaemic shock due to attempted suicide with tolbutamide and insulin. Ger Med Monthly 14: 14–19
Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS (1973) Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 9: 217–231
Creutzfeldt W, Creutzfeldt C, Frerichs H, Track NS, Arnold R (1976) Histochemistry, ultrastructure and hormone content of human insulinomas. In: Andreani D, Lefebvre P, Marks V (eds) Hypoglycemia. Proceedings of the European Symposium, Rome. Thieme, Stuttgart, pp 7–18
Crockford PM, Porte D, Wood FC, Williams RH (1966) Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism 15: 114–122
Davies DM, Maclntyre A, Millar E, Bell SM, Mehra SK (1967) Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs. Lancet 1: 363–364
Devrim S, Recant L (1966) Effect of glucagon on insulin release in vitro. Lancet 2: 1227–1228
Dowell RC, Imrie AH (1972) Chlorpropamide poisoning in non-diabetics. Scott Med J 17: 305–309
Elrick H, Arai Y, Yearwood-Drayton V (1957) Observation on actions of combined glucagon-insulin infusion in diabetic patients. J Clin Invest 36: 887–888
Elrick H, Witten TA, Arai Y (1958) Glucagon treatment of insulin reactions. N Engl J Med 258: 476–480
Esquibel AJ, Kurland AA, Mendelsohn D (1958) The use of glucagon in terminating insulin coma. Dis Nerv Syst 19: 485–486
Falorni A, Massi-Benedetti F, Sposito M, Barboni G, Latom M (1979) Insulin and glucagon secretion in the ketotic (idiopathic glucagon unresponsive) hypoglycemia of childhood. J Endocrinol Invest 2: 51–57
Fernandez J (1980) Hepatic glycogenosis: diagnosis and management. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, pp 297–312
Fernandez J, Koster JF, Grose WFA, Sorgedrager N (1974) Hepatic phophorylase deficiency: its differentiation from other hepatic glycogenoses. Arch Dis Child 49: 186–191
Finegold DN, Stanley CA, Baker L (1980) Glycemic response to glucagon during fasting hypoglycaemia: an aid to the diagnosis of hyperinsulinism. J Pediatr 96: 257–260
Fiser RH, Meisher HL, Fischer DA (1974) Hepatic phosphoenolypyruvate carboxykinase (PEPCK) deficiency: a new cause of hypoglycemia in childhood ( Abstr ). Pediatr Res 8: 432
Foä PP, Dunbar JC, Klein SP, Levy SH, Malik MA, Campbell BB, Foä NL (1980) Reactive hypoglycemia and A-cell (pancreatic) glucagon deficiency in the adult. JAMA 244: 2281–2285
Forman BH, Feeney E, Boas L (1974) Drug induced hypoglycemia. JAMA 229: 522
Forrest JAH (1974) Chlorpropamide overdosage. Delayed and prolonged hypoglycemia. Clin Toxicol 7: 19–24
Frasier SD, Smith FG, Nash A (1965) The use of glucagongel in idiopathic spontaneous hypoglycemia of infancy. Pediatrics 35: 120–123
Frerichs H, Willms B, Kasper H, Creutzfeldt C, Creutzfeldt W (1970) Contribution to the pathogenesis of tumour hypoglycaemia. Eur J Clin Invest 1: 2–11
Frey HMM, Roselund B (1970) Studies in patients with chlorpropamide-induced hypoglycemia. Diabetes 19: 930–937
Friend JAR, Hales CN (1965) Spontaneous hypoglycaemia and sarcoma. Acta Endocrinol (Copenh) 50: 233–238
Froesch ER (1978) Essential fructosuria: hereditary fructose intolerance and fructose 1,6- diphosphatase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 4th edn. McGraw-Hill, New York, pp 121–136
Gibbs GE, Ebers DW, Meckel BR (1958) Use of glucagon to terminate insulin reactions in diabetic children. Nebr State Med J 43: 56–57
Goldfine ID, Cerasi E, Luft R (1972) Glucagon stimulation of insulin release in man: inhibition during hypoglycemia. J Clin Endocrinol Metab 35: 312–315
Gotlin RW, Silver HK (1970) Neonatal hypoglycaemia, hyperinsulinism, and absence of pancreatic alpha-cells. Lancet 1: 1346
Greenman L (1950) Alterations in blood glucose following intravenous galactose. J Biol Chem 183: 577–585
Grill V, Cerasi E, Wahren J (1979) Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man. Scand J Clin Invest 39: 689–696
Grollman A, McCaleb WE, White FN (1964) Glucagon deficiency as a cause of hypoglycemia. Metabolism 13: 686–690
Grunt JA, McGarry ME, McCollum AT, Gould JB (1970) Studies of children with ketotic hypoglycemia. Yale J Biol Med 42: 420–438
Habbick BF, McNeish AS, Stephenson JBP (1971) Diagnosis of ketotic hypoglycaemia of childhood. Arch Dis Child 46: 295–300
Haro EN, Blum SF, Faloon WW (1965) The glucagon response of fasting obese subjects. Metabolism 14: 976–984
Haunz EA (1962) Feigned insulin reactions in diabetic children prevented by glucagon. Lancet 82: 263–268
Hoffbrand BI, Sevitt LH (1966) Use of mannitol in prolonged coma due to insulin overdose. Lancet 1: 802
Hommes FA, Bendien K, Elema JD, Bremer HJ, Lombeck I (1976) Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand 65: 233–240
Hommes FA, Schrijver J, Dias T (1980) Pyruvate carboxylase deficiency; studies on patients and on an animal model system. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, pp 269–286
Horwitz DL, Rubenstein AH (1974) Insulin suppression (letter). Lancet 2: 1021
Howell RR (1978) The glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. Blakiston, New York, pp 137–159
Hubble D (1954) Glucagon and glycogen storage disease of the liver. Lancet 1: 235–237
Hug G (1962) Glucagon tolerance test in glycogen storage disease. J Pediatr 60: 545–549
Hug G, Krill CE, Perrin EV, Guest GM (1963) Cori’s disease (amylo 1,6 glucosidase deficiency): report of a case in a negro child. N Engl J Med 268: 113–120
Jacobs RF, Nix RA, Paulus JE, Kiel EA, Fiser RH (1978) Intravenous infusion of diazoxide in the treatment of chlorpropamide-induced hypoglycemia. J Pediatr 93: 801–803
Jaffe R, Hashida Y, Yunis EJ (1980) Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 42: 356–365
Joffe BI, Roach L, Baker S, Shires R, Sandler M, Seftel HC (1981) Failure to induce reactive hypoglycaemia by drinking a starch-based alcohol beverage (sorghum beer). Ann Clin Biochem 18: 22–24
Johnson SF, Schade DS, Peake GT (1977) Chlorpropamide-induced hypoglycemia. Successful treatment with diazoxide. Am J Med 63: 799–804
Kerr DS (1980) Epinephrine deficiency in children: fasting metabolism and response to 2-deoxyglucose. In: Andreani D, Lefebvre PJ, Marks V (eds) Current views on hypoglycaemia and glucagon. Academic Press, London New York, pp 409–412
Khurana RC, Klayton R, Jung Y, Gonzalez AR, Dhawer VPS, Corredor DG, Sieracki JC, Danowski TS (1971) Insulin and glucose patterns in control subjects and in proved insulinoma. Am J Med Sei 262: 115–118
Kollee LA, Monnens LA, Cejka V, Wilms RH (1978) Persistent neonatal hypoglycaemia due to glucagon deficiency. Arch Dis Child 53: 422–424
Kreisberg RA, Hershman JM, Spenney JG, Boshell BR, Pennington LF (1970) Biochemistry of extrapancreatic tumor hypoglycemia. Diabetes 19: 248–258
Kumar D, Mehtalia SD, Miller LV (1974) Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions. Ann Intern Med 80: 697–701
Kushner RS, Lemli L, Smith DW (1963) Zinc glucagon in the management of idiopathic hypoglycemia. J Pediatr 63: 111 1–1115
Landau BR, Levie HJ, Hertz R (1958) Prolonged glucagon administration in a case of hyperinsulinism due to disseminated isletcell carcinoma. N Engl J Med 259: 296–288
Langs HM, Friedberg D (1965) Stimulation of insulin secretion by glucagon. Clin Res 13: 548
Laqueur HP, LaBurt HA (1960) Experiences with low-zinc insulin, with semilente insulin, with glucagon and adrenalin-thiamin in insulin coma treatment. J Neuropsychiatry 2: 86–92
Lefèbvre P, Luyckx A (1966) Glucagon-stimulated insulin release. Lancet 1: 1040
Lefèbvre PJ, Luyckx AS, Lecomte M J (1976) Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. In: Andreani D, Lefèbvre PJ, Marks V (eds) Hypoglycemia. Proceedings of the European Symposium. Thieme, Stuttgart, pp 91–98
Lewis GM, Spencer-Peet J, Stewart KM (1963) Infantile hypoglycaemia due to inherited deficiency of glycogen synthetase in liver. Arch Dis Child 38: 40–48
Limbeck GA, Kelley YC (1965) “Double-barrel” glucagon test: correlation with enzyme assays in limit dextrinosis. Am J Dis Child 109:162–164
Lins PE, Efendic S (1979) Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate. Diabetes 28: 190–195
Ljungström B (1964) Glucagon treatment of spontaneous hyperglycemia (in Norwegian). Nord Med 71: 177–179
Lowe CU, Mosovich LL (1965) The paradoxical effect of alcohol on carbohydrate metabolism in four patients with liver glycogen disease. Pediatrics 35: 1005–1008
Lowe CU, Sokal JE, Mosovich LL, Sarcione EJ, Dobray BH (1962) Studies in liver glycogen disease. Effects of glucagon and other agents on metabolic pattern and clinical status. Am J Med 33: 4–19
MacCuish AC, Munro JF, Duncan LJP (1970) Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics. Lancet 2: 946–949
MacLaren NK, Cowles C, Ozand PT, Shuttee R, Cornblath M (1975) Glycerol intolerance in a child with intermittent hypoglycemia. J Pediatr 86: 43–49
Madison LL (1968) Ethanol-induced hypoglycemia. Adv Metab Disord 3: 85–109
Mahler RF (1976) Disorders of glycogen metabolism. Clin Endocrinol Metab 5: 579–598
Mariani MM, Loubatières A (1972) Récentes expériences concernant l’antagonisme entre certains sulfamides hypoglycemiants et le diazoxide. In: Austoni M, Scandellari C, Trissotto A, Federspil G (eds) Hypoglycaemia and diazoxide. Cedam, Padova, pp 33–49
Marks LJ, Steinke J, Podolsky S, Egdahl RH (1974) Hypoglycemia associated with neoplasia. Ann NY Acad Sci 230: 147–160
Marks V (1960) Response to glucagon by subjects with hyperinsulinism from islet cell tumours. Br Med J 1: 1539–1540
Marks V (1962) The investigation of hypoglycaemia. In: Pyke DA (ed) Disorders of carbohydrate metabolism. Pitman, London, pp 229–239
Marks V (1971) The biological significance of the insulinotropic effect of glucagon in man. In: Austoni M, Scandellari C, Federspil G, Trissotto A (eds) Current topics on glucagon. Cedam, Padova, pp 63–71
Marks V (1976) Hypoglycaemia. 2. Other causes. Clin Endocrinol Metab 5: 769–782
Marks V, Alberti KGMM (1976) Selected tests of carbohydrate metabolism. Clin Endocrinol Metab 5: 805–820
Marks Y, Rose FC (1981) Hypoglycaemia, 2nd edn. Blackwell, Oxford Marks V, Samols E (1966) Hypoglycaemia of non-endocrine origin (non-islet cell tumours). Proc R Soc Med 59:338–340
Marks V, Samols E (1968 a) Glucagon test for insulinoma: a chemical study in 25 cases. J Clin Pathol 21: 346–352
Marks V, Samols E ( 1968 b) Glucagon mediated insulin release in man. In: Levine R, Pfeiffer EF (eds) Mechanism and regulation of insulin secretion. Il Ponte, Milan, pp 285–308
Marks V, Samols E (1969) Diagnostic tests for evaluating hypoglycaemia. Excerpta Medica Int Congr Ser 172: 864–872
Marrack D, Rose FC, Marks Y (1961) Glucagon and tolbutamide tests in the recognition of insulinomas. Proc R Soc Med 54: 749–751
Marri G, Tyler J, Marks V, Samols E (1966) Stimolazione della secrezione insulinica nell’umo mediante glucagone. Minerva Med 57: 2733–2737
Marri G, Cozzolino G, Palumbo R (1968) Glucagon in sulphonylurea hypoglycaemia. Lancet 1: 303
McFadzean AJS, Young RTT (1969) Further observations on hypoglycaemia in hepatocellular carcinoma. Am J Med 47: 220–235
McKiddie MT, Buchanan KD, Abernethy RJ (1969) Plasma insulin studies in the diagnosis of insulinoma. Scott Med J 14: 200–208
McQuarrie I (1954) Idiopathic spontaneously occurring hypoglycemia in infants. Clinical significance of problems and treatment. Am J Dis Child 87: 399–428
McQuarrie I, Bell ET, Zimmerman B, Wright WS (1950) Deficiency of alpha cells of pancreas as possible etiological factor in familial hypoglycemosis. Fed Proc 9: 337
Mortensen O, Sondergaard G (1954) Galactosemia (galactose disease). Acta Paediatr Scand 43: 467–477
Muhe E, Schricker KT, Raithel D (1969) Die Behandlung spontaner Hypoglycämien bei einem inoperablen Leberzellkarzinom durch Glucagon. Dtsch Med Wochenschr 94: 1781–1785
Nabben FAE (1968) Transient hypoglycemia with leucine hypersensitivity not based on increased insulin production. Treatment with zinc glucagon (in Dutch). Maandschr Kindergeneeskd 36: 2–17
Nitzan M, Kowadlo-Silbergeld A (1966) Responses to glucagon and epinephrine, and glycogen reserves in children with nondiabetic ketosis. Isr J Med Sci 2: 683–689
Ohneda A, Maruhama Y, Itabashi H, Horigome K, Yanbe A, Ishii S, Chiba M, Kai Y, Abe R, Yamagata S (1975) Diagnostic value of intravenous glucagon test in insulinoma. Tohoku J exp Med 116: 205–211
O’Keefe SJD, Marks V (1977) Lunchtime gin and tonic: a cause of reactive hypoglycaemia. Lancet 1: 1286–1288
Paullada JJ, Lisci-Garmilla A, Gonzales-Angulo A, Jurado-Mendoza J, Quijano-Narezo M, Gomez-Peralta L, Doria-Medina M (1968) Hemangiopericytoma associated with hypoglycemia. Am J Med 44: 990–999
Perheentupa J, Pitkanen E, Nikkila EA, Somersalo O, Hakosalo J (1962) Hereditary fructose intolerance: a clinical study of four cases. Ann Paediatr 8: 221–235
Perkoff GT, Parker VJ, Hann RF (1962) The effects of glucagon in three forms of glycogen storage disease. J Clin Invest 41: 1099–1105
Pfeifer MA, Wolter CF, Samols E (1978) Management of chlorpropamide-induced hypoglycemia with diazoxide. South Med J 71: 606–608
Pfeiffer EM, Thum C, Raptis S, Beischer W, Ziegler R (1976) Hypoglycemia in diabetes. In: Andreani D, Lefebvre P, Marks Y (eds) Hypoglycemia. Procedings of the European Symposium. Thieme, Stuttgart, pp 112–126
Pincus I J, Rutman JZ (1953) Glucagon, the hyperglycemic agent in pancreatic extracts. Arch Intern Med 92: 666–667
Pi-Sunyer FX, van Itallie TB, Zintel HA (1969) Insulin stimulatory tests in a patient with islet cell adenoma. Am J Surg 118: 95–99
Porte D, Graber AL, Kuzuya T, Williams RH (1966) The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest 45: 228–236
Rizza RA, Gerich JE (1979) Persistent effect of sustained hyperglucagonaemia on glucose production in man. J Clin Endocrinol Metab 48: 352–355
Rosenbloom AL (1972) Ketotic (idiopathic glucagon unresponsive) hypoglycaemia: diazoxide effects. Arch Dis Child 47: 544–549
Rosenbloom AL, Smith DW, Cohan RC (1966) Zinc glucagon in idiopathic hypoglycemia of infancy. Am J Dis Child 112: 107–111
Rossi E (1959) Glucagon. Triangle 4: 13
Roth H, Thier S, Segal S (1966) Zinc-glucagon in the management of refractory hypoglycemia due to insulin-producing tumors. N Engl J Med 274: 493–497
Samols E, Holdsworth D (1968) Disturbances of carbohydrate metabolism: liver disease. In: Dickens F, Rändle PJ, Whelan WJ (eds) Carbohydrate metabolism and its disorders. Academic, London, pp 289–336
Samols E, Marks V (1963) Insulin assay in insulinomas. Br Med J 1: 507–510
Samols E, Marks V (1966) Application of insulin radioimmunoassay in diagnosis and clinical investigation. In: Proceedings of the conference on problems connected with the preparation and use of labelled proteins in tracer studies, Euratom, Pisa, pp 285–300
Samols E, Marri G, Marks V (1965) Promotion of insulin secretion by glucagon. Lancet 1: 415–516
Samols E, Marri G, Marks Y (1966) Interrelationship of glucagon, insulin, and glucose. The insulinogenic effect of glucagon. Diabetes 15: 855–866
Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM (1977) Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 297: 1029–1032
Schulman JL, Greben SE (1957) The effect of glucagon on the blood glucose level and the clinical state in the presence of marked insulin hypoglycemia. J Clin Invest 36: 74–80
Schulman JL, Saturen P (1954) Glycogen storage disease of the liver. I. Clinical studies during the early neonatal period. Pediatrics 14: 632–645
Service FJ, Horwitz DL, Rubenstein AH, Kuzaya H, Mako ME, Reynolds C, Molnar GD (1977) C-peptide suppression test for insulinoma. J Lab Clin Med 90: 180–186
Shipp JC, Delcher HK, Munroe JF (1964) Treatment of insulin hypoglycemia in a diabetic camp. A comparison of glucagon (1 and 2 mg) and glucose. Diabetes 13: 645–648
Sizonenko PC, Paunier L, Vallotton MB, Terraz M, Scholer-Markovic D (1972) Childhood hypoglycaemia: plasma glucose and renin response to deoxyglucose for assessment of adrenal medulla responsiveness. Helv Paediatr Acta 27: 565–573
Sokal JE, Lowe CU, Sarcione EJ, Mosovich LL, Doray BH (1961) Studies of glycogen metabolism in liver glycogen disease (von Gierke’s disease). Six cases with similar metabolic abnormalities and responses to glucagon. J Clin Invest 40: 364–374
Sokal JE, Lowe CJ, Sarcione EJ (1962) Liver glycogen disease (von Gierke’s disease). Arch Intern Med 109: 612–624
Spellberg MA (1969) Treatment of glycogen storage disease. Am J Gastroenterol 52: 45–47
Steinitz K (1967) Laboratory diagnosis of glycogen disease. Adv Clin Chem 9: 227–354
Stephenson JBP, Hainsworth IR (1966) Ketotic hypoglycaemia in childhood. Proc Assoc Clin Biochem 5: 80–81
Taunton OD, Greene HL, Stifel FB, Hofeldt FD, Lufkin EG, Hagler L, Herman Y, Herman RH (1978) Fructose-1,6-diphosphatase deficiency, hypoglycemia and response to folate therapy in a mother and her daughter. Biochem Med 19: 260–276
Taylor JR, Sherratt HSA, Davies DM (1978) Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia. Eur J Clin Pharmacol 14: 125–127
Tietze HU, Zurbriigg RP, Zuppinger J A, Joss EE, Kaser H (1972) Occurrence of impaired Cortisol regulation in children with hypoglycemia associated with adrenal medullary hyporesponsiveness. J Clin Endocrinol Metab 34: 948–958
Turner DS, Mclntyre N (1966) Stimulation by glucagon of insulin release from rabbit pancreas in vitro. Lancet 1: 351–352
Turner RC (1976) The diagnosis of insulinomas and other causes of fasting hypoglycaemia. In: Andreani D, Lefebvre P, Marks V (eds) Hypoglycemia: proceedings of the european symposium. ( Hormone and Metabolic Research Supplement Series) Thieme, Stuttgart, pp 40–45
Turner RC, Heding LG (1977) Plasma pro-insulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 13: 571–577
van Itallie TB (1956) Glucagon: physiological and clinical considerations. N Engl J Med 254: 794–803
van Itallie T, Bentley WBA (1955) Glucagon-induced hyperglycemia as an index of liver function. J Clin Invest 34: 1730–1737
Vidnes J, Oyasaeter S (1977) Glucagon deficiency causing severe neonatal hypoglycemia in a patient with normal insulin secretion. Pediatr Res 11: 943–947
Vidnes J, Sovik O (1976) Gluconeogenesis in infancy and childhood. III. Deficiency of the extramitochondrial form of hepatic phosphoenolpyruvate carboxykinase in a case of persistent neonatal hypoglycaemia. Acta Paediatr Scand 65: 307–312
Wagner T, Spranger J, Brunck HJ (1969) Kongenitaler-a-Zellmangel als Ursache einer chronischen infantilen Hypoglykämie? Monatsschr Kinderheilkd 117: 236–238
Waife SO (1960) An integrated view of glucagon. J Mich Med Soc 59: 1519–1523
Weinges KF (1959) Der Einfluß eines protrahiert wirkenden Glucagons auf den Blutzucker, das anorganische Serumphosphat und die Gesamtaminosäuren im Serum. Naunyn Schmiedebergs Arch J Exp Pathol 237: 22–26
Widström A, Cerasi E (1973) On the action of tolbutamide in normal man. III. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response. Acta Endocrinol (Copenh) 72: 532–544
Yakovac WC, Baker L, Hummeler K (1971) Beta cell nesidioblastosis in idiopathic hypoglycemia of infancy. Pediatrics 79: 225–231
Zuppinger KA (1975) Hypoglycemia in childhood. Evaluation of diagnostic procedures. Karger, Munich
Zuppinger KA, Rossi E (1969) Metabolic studies in liver glycogen disease with special reference to lactate metabolism. Helv Med Acta 35: 406–422
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marks, V. (1983). Glucagon in the Diagnosis and Treatment of Hypoglycaemia. In: Lefebvre, P.J. (eds) Glucagon II. Handbook of Experimental Pharmacology, vol 66 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69019-8_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-69019-8_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69021-1
Online ISBN: 978-3-642-69019-8
eBook Packages: Springer Book Archive